Lupin Insists It Will Rebuild Quality Reputation Following Latest FDA Action
Indian Firm Moves On From Warning Letter As Goa Plant Gets VAI Status
Lupin says it is rebuilding its reputation for quality and compliance after the US FDA awarded VAI status to a manufacturing facility in Goa that was hit by a warning letter back in 2017.
